Recombinant Human Relaxin (rhRlx)

Relaxin · Corthera, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Human Relaxin (rhRlx), covering 2009-04-15 to 2009-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure [Phase 2]